The company said there was insufficient data to allow using a cure for PTSD that consists of the drug often called Ecstasy.Times ahead of the panel vote in June, an independent Assessment by the Institute for Clinical and Financial Critique, a nonprofit that assessments medications as well as their expenditures, found there was inadequate evidence